📖 Approx. 9 min
The dissolution of a medical corporation is a critical decision that extinguishes its legal personality and involves complex issues extending far beyond mere procedural formalities. Particularly when considering healthcare business succession or M&A, if a transfer proves difficult or if dissolution is chosen as an option when not continuing operations, it is essential to proceed with caution. This requires an accurate understanding of the corporation type (with or without equity interest), the attribution of residual assets, and the relevant legal and tax issues. This article provides a comprehensive overview of medical corporation dissolution procedures, practical considerations for distributing residual assets in both corporations with and without equity interest, and critical tax matters from a perspective tailored to the healthcare industry.
Basic Flow and Types of Medical Corporation Dissolution
The dissolution of a medical corporation entails statutory regulations and administrative procedures distinct from those of ordinary commercial companies. Grounds for dissolution are diverse, including resolutions passed at general meetings of members, the occurrence of events specified in the articles of incorporation, bankruptcy, mergers, and the revocation of incorporation approval. The most common ground is a resolution adopted at a general meeting of members due to the lack of a successor or managerial reasons. When dissolution is resolved, legal personality does not vanish immediately; rather, it is extinguished upon the completion of liquidation proceedings. The primary objectives throughout this liquidation process are to reorganize the corporation’s assets, settle its liabilities, and distribute any residual assets.
The key steps from dissolution to the conclusion of liquidation generally proceed as follows:
- Occurrence of Grounds for Dissolution / Resolution to Dissolve: Grounds for dissolution arise, such as the passage of a resolution at a general meeting of members.
- Application for Approval of Dissolution: An application for dissolution approval is submitted to the prefectural governor (or the Minister of Health, Labour and Welfare).
- Appointment of Liquidator: While the board chairman or representative director typically assumes the role of liquidator, someone else can also be appointed separately at a general meeting of members.
- Registration of Dissolution: Following approval, the dissolution is registered at the Legal Affairs Bureau.
- Commencement of Liquidation Proceedings: The liquidator prepares an inventory of assets and a balance sheet, and initiates creditor protection procedures (public notice in the Official Gazette [Kanpo] and individual notices to known creditors).
- Settlement of Liabilities and Collection of Receivables: Outstanding corporate liabilities are satisfied, and receivables such as uncollected medical fees are gathered.
- Determination and Distribution of Residual Assets: Assets remaining after settling all liabilities are distributed according to the specific type of medical corporation.
- Application for Approval of Conclusion of Liquidation: Once the distribution of residual assets is complete, an application for approval of the conclusion of liquidation is submitted to the prefectural governor, etc.
- Registration of Conclusion of Liquidation: Following approval, the conclusion of liquidation is registered at the Legal Affairs Bureau, and the legal personality is completely extinguished.
During medical corporation dissolution procedures, administrative actions pursuant to the Medical Care Act—such as submitting a notification of clinic closure—are required concurrently. These procedures, especially regarding the handling of residual asset distribution, differ substantially depending on whether the entity is a “medical corporation with equity interest” or a “medical corporation without equity interest.”
Residual Asset Distribution in Medical Corporations with Equity Interest
Due to the historical background of their establishment, medical corporations with equity interest grant members an equity stake in the corporation’s assets proportional to the amount they contributed. This serves as the basis for a member’s right to claim a return of their equity interest up to the contributed amount upon withdrawal or upon the corporation’s dissolution. However, under the reform of the medical corporation system, medical corporations established on or after April 1, 2007, are in principle not permitted to issue equity interests; therefore, this category is limited strictly to entities founded prior to that date.
Valuing and refunding equity interests at the time of dissolution involves complexities not found in ordinary business dissolutions. In the case of a member’s withdrawal during ongoing operations, an amount corresponding to their equity stake at the time of withdrawal is typically refunded according to the articles of incorporation. In contrast, upon dissolution, residual assets are finalized through liquidation proceedings, and distributions corresponding to equity interests are made strictly within that remaining amount. At this juncture, the valuation of an equity interest does not necessarily match its nominal book value at the time of contribution; rather, it is generally revalued based on the corporation’s net asset value at the time of dissolution.
Difficulties in Valuing Equity Interest Redemptions
The valuation of equity interests requires a fair market valuation of a wide array of assets and liabilities, including real estate, medical equipment, pharmaceutical inventories, uncollected medical fees, and outstanding liabilities. In particular, medical equipment undergoes rapid technological advancement and obsolescence, often causing substantial disparities between book value and fair market value. In addition, revisions to medical fee schedules, the rollout of regional medical care visions, and stricter facility standards can dictate future profitability, which in turn influences the valuation of the medical corporation’s assets. Objective assessments by qualified specialists are essential to evaluate all these factors comprehensively.
When residual assets are finalized and an amount corresponding to equity interests is returned to members, any portion exceeding the original contribution may be treated as a “deemed dividend” and subjected to capital gains or miscellaneous income taxation at the individual level. Meanwhile, at the corporate level, corporate income tax and enterprise tax may be levied on gains from asset sales or revaluation gains during the business year of dissolution or liquidation. Because these tax implications are substantial, conducting thorough projections in advance and coordinating closely with tax specialists is imperative.
Residual Asset Distribution and Funds in Medical Corporations Without Equity Interest
Medical corporations established on or after April 1, 2007, are, as a rule, incorporated without equity interest. Furthermore, existing medical corporations with equity interest are permitted to transition to non-equity status in accordance with the legislative intent of the medical corporation reforms. The defining characteristic of a medical corporation without equity interest is that distributing surplus profits to members is prohibited, and any residual assets upon dissolution must revert to the national treasury, local public entities, or another medical or public-interest corporation designated in the articles of incorporation. This rule is grounded in the foundational principle that medical corporations are highly public-serving institutions with strict non-profit requirements.
When establishing a medical corporation without equity interest, the “fund” (Kikin) system is often utilized. A fund is a mechanism to contribute working capital required for incorporation and operations; unlike an equity investment, it confers no ownership shares or equity stakes upon the members. The handling of funds upon dissolution differs substantially from equity interests. As a rule, after corporate debts are settled and before residual assets revert to the national treasury, etc., the fund is returned to contributors up to the original contributed amount. However, because refunds depend on the financial condition of the corporation, a full return is not guaranteed.
The following table outlines the key differences in residual asset distribution between medical corporations with and without equity interest:
| Item | Medical Corporation With Equity Interest | Medical Corporation Without Equity Interest |
|---|---|---|
| Distribution of Surplus Profits | Prohibited in principle (with minor historical exceptions) | Prohibited |
| Attribution of Residual Assets | Distributed to members (investors) based on equity interest | National treasury, local public entities, or other medical/public-interest corporations (as designated in the articles) |
| Treatment of Fund (Kikin) | System not applicable | Returned to contributors after debt settlement upon dissolution (capped at contribution amount) |
| Establishment Date Benchmark | On or before March 31, 2007 | On or after April 1, 2007 |
Special categories such as Specified Medical Corporations and Social Medical Corporations are also classified as non-equity medical corporations; while enjoying favorable tax treatment, they are subject to far more stringent regulatory standards and oversight. Upon the dissolution of these corporations, residual assets must fundamentally revert to the national treasury or designated public bodies.
Practical Considerations in Liquidation Proceedings
The liquidation process of a medical corporation is not merely an exercise in paperwork; it is a vital procedure designed to orderly wind down assets and protect the rights of creditors and stakeholders. Appointed liquidators must first compile an inventory of assets and a balance sheet as of the dissolution date to clarify the corporation’s financial standing. Subsequently, they must collect outstanding claims and settle debts.
Of paramount importance is the “creditor protection procedure.” Liquidators must publish a dissolution notice in the Official Gazette (Kanpo), calling upon creditors to declare their claims within a specified statutory period. Liquidators are also obligated to send individual notices to known creditors. While claims not submitted within this window risk being excluded from the liquidation distribution, procedural defects can trigger nullification of the liquidation or personal liability for liquidators, necessitating the utmost care.
Claims and liabilities unique to healthcare institutions include uncollected medical fees, outstanding pharmaceutical accounts payable, medical equipment lease obligations, and employee severance liabilities. Accurately identifying and resolving these balances is essential for smooth liquidation. For instance, collecting unpaid medical remuneration from public health insurers can be time-consuming, which may prolong the liquidation schedule. Furthermore, severance packages and unpaid wages arising from employee dismissals must be settled strictly in compliance with labor regulations.
Tax returns—including corporate tax and consumption tax—must continue to be filed throughout the liquidation process. Because dissolution and liquidation business years require tax accounting distinct from standard operating years, close collaboration with a certified tax accountant is crucial.
Additionally, filings with regulatory bodies—such as submitting clinic closure notifications and surrendering facility standards certifications—must not be overlooked. Failure to complete these filings may invite unexpected administrative guidance or statutory penalties. When conducting an asset transfer alongside healthcare succession, determining whether the acquirer can maintain existing facility standards or must secure fresh regulatory approvals is another critical issue to evaluate simultaneously with the dissolution.
Critical Tax Considerations in Medical Corporation Dissolution
The dissolution of a medical corporation carries multifaceted tax implications for both the entity and—in corporations with equity interest—individual members. Anticipating these issues and devising preemptive measures is vital to mitigate unanticipated tax liabilities.
First, on the corporate side, tax returns for corporate tax, local enterprise tax, and consumption tax must be submitted for the dissolution business year and each liquidation business year. In particular, if realized capital gains or valuation gains arise when selling or revaluing corporate assets (such as land, buildings, or medical devices) during liquidation, these gains constitute taxable income. For instance, if real property is sold at a price significantly exceeding its book value, corporate taxes will be levied on the margin.
For medical corporations with equity interest, when a member receives a refund that exceeds their initial capital contribution, that excess portion may be taxed as a “deemed dividend” or capital gain. This stems from the fact that it is substantively treated as a dividend distribution from the corporation. In calculating capital gains, the difference between the acquisition cost (contribution amount) and the transfer income (refunded amount) becomes subject to tax, generally consolidated with other income under aggregate taxation. However, specific tax treatment may apply depending on the nature of underlying real estate and assets transferred.
Even following the formal conclusion of liquidation, tax audits remain a possibility. Tax authorities tend to scrutinize the validity of asset valuations, the adequacy of creditor protection measures, and the legality of residual asset allocation. It is therefore crucial to maintain comprehensive documentation and conduct all operations transparently with expert guidance.
Due to the nature of medical corporation dissolution, pivoting or reversing course once proceedings have started is exceedingly difficult, and reconciling the interests of various stakeholders is complex. Because the process demands specialized expertise spanning healthcare law, corporate accounting, tax strategy, and administrative filings, partnering with an experienced advisory team is key to a smooth outcome.
Dissolving a medical corporation is a delicate endeavor requiring comprehensive technical knowledge and intricate procedural compliance. In particular, meticulous planning and execution by qualified advisors are indispensable when dealing with the allocation of residual assets based on equity status, creditor notifications, administrative regulatory steps, and entity- as well as individual-level tax treatments. At M&A Medical, our industry-dedicated professionals deliver end-to-end support—ranging from medical corporation dissolution and liquidation consulting to evaluating medical succession and business transfers via healthcare M&A. If you are a board chairman or clinic director facing these complex decisions, please do not hesitate to contact us for a confidential, complimentary consultation.
Contact M&A Medical for Healthcare Business Succession Inquiries
M&A Medical is a specialized advisory firm dedicated to healthcare M&A and succession support. As a recognized M&A support agency accredited by the Small and Medium Enterprise Agency, we support clinic and medical corporation divestments facing successor shortages through to strategic acquisitions on a full success-fee basis.
- Initial consultation and preliminary valuation are free of charge
- 0 yen retainer or monthly fees (success-fee only model)
- Strict confidentiality guaranteed (proceeding under NDA)
- Covering all 47 prefectures and all medical specialties across Japan
Whether you simply want to understand market valuations, are concerned about lacking a successor, or wish to explore joining a medical group, please feel free to reach out to us at the earliest stage of your consideration.